A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)
Phase 3
Completed
- Conditions
- Osteoporosis, Postmenopausal
- Registration Number
- NCT00092040
- Lead Sponsor
- Organon and Co
- Brief Summary
The purpose of this study and 12 month extension is to evaluate the effects of two investigational drugs on osteoporosis in postmenopausal women.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 936
Inclusion Criteria
- Postmenopausal women with osteoporosis
Exclusion Criteria
- Any known allergy to the study drug
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Mean percent change from baseline in hip trochanter bone mineral density (BMD)
- Secondary Outcome Measures
Name Time Method Mean percent change from baseline in PA lumbar spine, total hip, and femoral neck BMD